Efficacy of immunosuppressive regimens for survival of stem cell-derived grafts

Researchers identify safer and more effective immunosuppression strategies to support the survival of stem cell-derived cardiomyocyte grafts

2026-01-28

(Press-News.org)

While current clinical trials for cardiac regeneration using induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) employ immunosuppressive regimens used in heart transplants, the precise immunosuppressive regimen needed remains elusive. Now, researchers have identified optimized immunosuppressive strategies that allow transplanted iPSC-CMs to survive without immune rejection in non-human primates. These findings advance the clinical potential of regenerative therapies for severe heart failure, addressing a major challenge in translating stem cell science into effective human treatments.

Heart failure remains one of the most pressing global health challenges, affecting millions of people and often progressing despite optimal medical care. While heart transplantation can be life-saving, the severe shortage of donor organs and the long-term risks of lifelong immunosuppression significantly limit its usability. Regenerative medicine offers a promising alternative, replacing damaged heart muscle cells with cardiomyocytes derived from induced pluripotent stem cells. However, ensuring that these transplanted cells survive without immune rejection remains a critical barrier to clinical success.

In a new study, a research team led by Assistant Professor Hajime Ichimura and Mr. Shuji Chino from the Division of Cardiovascular Surgery, Department of Surgery, Shinshu University School of Medicine, Japan, along with Dr. Shugo Tohyama from the Fujita Medical Innovation Center Tokyo, Fujita Health University, Japan, and Dr. Shin Kadota and Dr. Yuji Shiba from the Department of Regenerative Science and Medicine, Institute for Biomedical Science, Shinshu University, Japan, set out to clarify how the immune system responds to allogeneic induced pluripotent stem cell-derived cardiomyocyte (iPSC-CM) transplantation. Their work specifically examined the efficacy of immunosuppressive regimens commonly used in heart transplantation for stem cell-based cardiac repair. The study was published in Cardiovascular Research on November 18, 2025.

“Current clinical trials for cardiac regeneration using iPSC-CMs employ immunosuppressive regimens similar to those used in heart transplants. However, the optimal and precise level of immunosuppression required after transplantation remains unclear. To unveil this, we explored safer and more effective immunosuppressive regimens for use during iPSC-CM transplantation,” says Dr. Ichimura.

The researchers used cynomolgus monkeys, whose immune systems closely resemble those of humans. After inducing myocardial injury, the team transplanted large numbers of allogeneic iPSC-CMs into the hearts of the animals. Different combinations of immunosuppressive drugs were tested, including corticosteroids, methylprednisolone, calcineurin inhibitors, mycophenolate mofetil, and the co-stimulation blocker abatacept. This rigorous experimental approach allowed the researchers to systematically determine which specific drug combinations were sufficient and necessary for graft survival in a primate model.

The results showed that a triple-drug regimen consisting of methylprednisolone, calcineurin inhibitors, and mycophenolate mofetil reliably prevented acute immune rejection of the transplanted cardiomyocytes. When any one of these components was removed, immune cells rapidly rejected the graft, underscoring the need for all three immunosuppressants.

Importantly, the study also explored ways to reduce long-term reliance on steroids, which are associated with serious side effects such as metabolic issues and bone density loss. The researchers found that replacing mycophenolate mofetil with abatacept allowed steroids to be discontinued without triggering immune rejection. This steroid-free approach represents a significant step forward, as it may improve long-term safety and overall quality of life for future patients receiving stem cell-based cardiac therapies.

Beyond immune rejection, the study addressed another major challenge in cardiac cell therapy: post-transplant arrhythmias. Some transplanted cardiomyocytes displayed immature electrical properties, increasing the risk of dangerous heart rhythm disturbances. The team demonstrated that treatment with commonly used antiarrhythmic drugs, amiodarone and ivabradine, dramatically reduced arrhythmia incidence and prevented sudden cardiac death in the primate model.

The broader significance of this research lies in its translational relevance. Clinical trials using iPSC-CMs are already underway, but optimal immunosuppressive strategies have remained unclear. This study provides strong preclinical evidence that carefully tailored immunosuppression is essential for graft survival and that alternative drug combinations may allow safer, steroid-free protocols.

“Our study sheds light on the importance of optimized immunosuppressant regimens for iPSC-CM graft survival. It further highlights the potential improvements in clinical outcomes in patients with severe heart failure. However, further studies are needed to validate these findings and refine immunosuppressive strategies for the widespread clinical use of allogeneic iPSC-CMs in cardiac regeneration,” concludes Mr. Chino.

# # # # #

About Shinshu University

Shinshu University is a national university founded in 1949 and located nestling under the Japanese Alps in Nagano known for its stunning natural landscapes.

Shinshu University was selected for the Forming Japan’s Peak Research Universities (J-PEAKS) Program by the Japanese government. This initiative seeks to promote the formation of university consortia that will enhance research capabilities across Japan.

Our motto, "Powered by Nature - strengthening our network with society and applying nature to create innovative solutions for a better tomorrow" reflects the mission of fostering promising creative professionals and deepening the collaborative relationship with local communities, which leads to our contribution to regional development by innovation in various fields. We’re working on providing solutions for building a sustainable society through interdisciplinary research fields: material science (carbon, fiber and composites), biomedical science (for intractable diseases and preventive medicine) and mountain science, and aiming to boost research and innovation capability through collaborative projects with distinguished researchers from the world. For more information visit https://www.shinshu-u.ac.jp/english/ or follow us on X (Twitter) @ShinshuUni for our latest news.

About Assistant Professor Hajime Ichimura from Shinshu University School of Medicine, Japan

Dr. Hajime Ichimura is an Assistant Professor at the Division of Cardiovascular Surgery, Department of Surgery, Shinshu University School of Medicine, Japan. His research focuses on the intersection of cardiovascular surgery and regenerative medicine, with a primary emphasis on developing innovative stem cell-based therapies for complex heart diseases. To date, he has authored 30 influential scientific publications and has earned over 1,054 citations.

About Mr. Shuji Chino from Shinshu University School of Medicine, Japan

Mr. Shuji Chino is a researcher at the Division of Cardiovascular Surgery, Department of Surgery, Shinshu University School of Medicine, Japan. His work centers on surgical and regenerative approaches to cardiovascular disease, with a strong interest in translating experimental findings into clinical solutions. Through collaborative research, he contributes to advancing stem cell-based therapies and improving outcomes for patients with severe heart conditions.

END

ELSE PRESS RELEASES FROM THIS DATE:

Glowing bacterial sensors detect gut illness in mice before symptoms emerge

2026-01-28

UBC researchers have engineered gut bacteria that dim their fluorescent glow in the presence of illness. Their findings, published in Cell today, could improve how we diagnose problems in the gut by using bacteria that already live there. “Our biosensors could improve the ability to predict how diseases in the gut progress, identifying early changes that could aid preventative interventions,” said co-first author Juan Camilo Burckhardt (he/him), a doctoral candidate in the department ...

GLP-1 RAs and prior major adverse limb events in patients with diabetes

2026-01-28

About The Study: In this nationwide cohort study of patients with diabetes and prior major adverse limb events, treatment with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) was associated with significantly lower risks of recurrent limb events, cardiovascular events, all-cause mortality, and kidney disease progression compared with dipeptidyl peptidase-4 inhibitors. These findings support the preferential use of GLP-1 RAs for secondary prevention in this high-risk population. Corresponding Author: To contact the corresponding ...

Life-course psychosocial stress and risk of dementia and stroke in middle-aged and older adults

2026-01-28

About The Study: In this cohort study, exposure to adverse experiences throughout life was associated with increased risks of dementia and stroke, with depression mediating these associations. These findings highlight the importance of implementing life-course interventions that address both psychological trauma and mental health to reduce the burden of neurovascular diseases. Corresponding Authors: To contact the corresponding authors, email Jianhui Zhao, MPH, PhD, (jzhao40@mgh.harvard.edu) and Shan Liu, PhD, (graystar92@163.com). To ...

Cells have a built-in capacity limit for copying DNA, and it could impact cancer treatment

2026-01-28

For almost 60 years, scientists have tried to understand why DNA doesn’t replicate wildly and uncontrollably every time a cell divides – which they need to do constantly. Without this process, we would die. These essential, ongoing cell divisions involve a cell copying its unique genetic material, DNA, and then forming new cells. Cells know exactly when and how to do this during the roughly 24 hours it takes to complete a division, and they also know what type of cell they should become: a liver cell, a brain cell, or a skin cell. If cells were to launch into random DNA replication, they would quickly run out of resources, and the timing ...

Study finds longer hospital stays and higher readmissions for young adults with complex childhood conditions

2026-01-28

Young adults with complex chronic childhood-onset conditions such as sickle cell disease and cystic fibrosis experience longer hospital stays, higher readmission rates and greater use of resources in adult hospitals, according to a new study in JAMA Network Open. More children with medically complex conditions are surviving into adulthood, but researchers have had limited visibility into how these conditions influence adult hospital care. Led by a team at The Hospital for Sick Children (SickKids), the study shows that while this group represents 6.7 ...

Study maps how varied genetic forms of autism lead to common features

2026-01-28

UCLA Health researchers have created a comprehensive map showing how eight different genetic mutations associated with autism spectrum disorder affect early brain development, providing new insights into the ways diverse genetic causes may lead to shared features and symptoms of the disorder. Genetic studies performed over the past two decades have identified more than 100 genes harboring rare mutations linked to autism. This genetic heterogeneity has raised a fundamental question: if autism can be caused by so many different ...

New chip-sized, energy-efficient optical amplifier can intensify light 100 times

2026-01-28

Light does a lot of work in the modern world, enabling all types of information technology from TVs to satellites to fiber-optic cables that carry the internet across oceans. Stanford physicists recently found a way to make that light work even harder with an optical amplifier that requires low amounts of energy without any loss of bandwidth, all on a device the size of a fingertip. Similar to sound amplifiers, optical amplifiers take a light signal and intensify it. Current small-sized optical amplifiers need a lot of power to function. The new optical amplifier, detailed in ...

New light-based platform sets the stage for future quantum supercomputers

2026-01-28

A light has emerged at the end of the tunnel in the long pursuit of developing quantum computers, which are expected to radically reduce the time needed to perform some complex calculations from thousands of years down to a matter of hours. A team led by Stanford physicists has developed a new type of “optical cavity” that can efficiently collect single photons, the fundamental particle of light, from single atoms. These atoms act as the building blocks of a quantum computer by storing “qubits” – the quantum version of a normal computer’s bits of zeros and ones. This work enables that process for ...

Pesticides significantly affect soil life and biodiversity

2026-01-28

Seventy percent of soils in Europe are contaminated with pesticides. A Europe-wide study co-led by researchers of the University of Zurich now shows that their effects on soil life are substantial, as pesticides suppress various beneficial soil organisms. To protect soil biodiversity, the findings should be taken into account in current pesticide regulations. Life beneath our feet is essential for maintaining critical ecosystem functions and services like food production, carbon storage, erosion control and water regulation. An international study now provides the first comprehensive quantitative evidence of the prevalence and impact of agricultural pesticides in European soils. According ...

Corals sleep like us, but their symbiosis does not rest

2026-01-28

Sleep is essential for much of the animal kingdom. During the night, neuron and tissue repair mechanisms are activated to aid recovery from daily activity. This is risky: organisms that sleep are more vulnerable to predators. However, the phenomenon extends from mammals to invertebrates. Nevertheless, until now it was not known whether other, more ancient groups without neurons, such as corals, engage in any kind of nocturnal rest. A study led by the Institute of Evolutionary Biology (IBE), a joint research center of the Spanish National Research Council (CSIC) and Pompeu Fabra University (UPF), has revealed ...